Liraglutide (204656-20-2)
Product Summary
Liraglutide (204656-20-2) is a GLP-1 receptor agonist for type 2 diabetes & weight management. Features glucose-dependent insulin secretion, appetite control, and cardiovascular protection. White powder stored at -20°C. For R&D use.
Product Custom Attributes
Product Description
Liraglutide is an artificially synthesized glucagon-like peptide-1 (GLP-1) receptor agonist, mainly used for the treatment of type 2 diabetes and long-term weight management.
Mechanism of action:
- Blood sugar regulation: Stimulates insulin secretion in a glucose concentration-dependent manner, while reducing glucagon secretion, thereby lowering blood sugar levels.
- Weight control: By delaying gastric emptying and acting on specific areas of the brain to control appetite and food intake, it increases satiety.
- Cardiovascular protection: Has multiple protective effects on the cardiovascular system, including lowering systolic blood pressure.
*The product under patent is only for R&D use.
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
